Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background—: In heart failure (HF) with reduced ejection fraction, randomized trials of statins did not demonstrate improved outcomes. However, randomized trials may not always be generalizable. The aim was to determine whether statins are associated with improved outcomes in an unselected nationwide population of patients with HF with reduced ejection fraction overall and in relation to ischemic heart disease (IHD). Methods and Results—: In the Swedish Heart Failure Registry, 21 864 patients with HF with reduced ejection fraction (age ± SD, 72±12 years; 29% women), of whom 10 345 (47%) were treated with statins, were studied. Propensity scores for statin use were derived from 42 baseline variables. The associations between statin use and outcomes were assessed with Cox regressions in a population matched 1:1 based on propensity score and age and in the overall population with adjustment for propensity score and age. The primary outcome was all-cause mortality; secondary outcomes were cardiovascular mortality; HF hospitalization; and combined all-cause mortality or cardiovascular hospitalization. Survival at 1 year in the matched population was 83% for statin-treated versus 79% for untreated patients (hazard ratio, 0.81; 95% confidence interval, 0.76–0.86; P <0.001). In the unmatched population, 1-year survival was 85% for statin-treated versus 79% for untreated patients, hazard ratio after adjustment for propensity score and age was 0.84 (95% confidence interval, 0.80–0.89; P <0.001). No examined baseline variables interacted with statin use except for IHD ( P =0.001), with a hazard ratio of 0.76 (95% confidence interval, 0.70–0.82, P <0.001) with IHD and 0.95 (95% confidence interval, 0.85–1.07; P =0.430 without IHD. Statin use was also associated with reduced risk for all 3 secondary outcomes. Conclusions—: In an unselected nationwide population of patients with HF with reduced ejection fraction, statins were associated with improved outcomes, specifically in the presence of IHD. This contrasts with previous randomized controlled trials. Additional randomized controlled trials with more generalized inclusion or focused on IHD may be warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055 · cited 1×
“Revascularisation, n (%) 23 2 1380 (12) 4857 (48) 78* 1240 (24) 1383 (26) 6*”
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
Khush, K. K., Waters, D. D., Bittner, V., Deedwania, P. C., Kastelein, J. J. P., Lewis, S. J., & Wenger, N. K. (2007) · Circulation · doi:10.1161/circulationaha.106.625574 · Cited by 172
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
Rogers, J. K., Jhund, P. S., Perez, A.-C., Böhm, M., Cleland, J. G., Gullestad, L., Kjekshus, J., van Veldhuisen, D. J., Wikstrand, J., Wedel, H., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.12.007 · Cited by 138 · cited 2×
“Women, n (%) 3737 (32) 2586 (25) 16* 1579 (29) 1555 (29) 1”
Cited by
Vedin, O., Lam, C. S. P., Koh, A. S., Benson, L., Teng, T. H. K., Tay, W. T., Braun, O. Ö., Savarese, G., Dahlström, U., & Lund, L. H. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003875 · Cited by 289
Self-citationPacker, M., Lam, C. S. P., Lund, L. H., Maurer, M. S., & Borlaug, B. A. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1902 · Cited by 185
Self-citationAlehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002143 · Cited by 109
“Former, n (%) 1458 (36) 1201 (46) 19 634 (42) 613 (41) 2”
Self-citationBielecka-Dabrowa, A., Bytyçi, I., Von Haehling, S., Anker, S., Jozwiak, J., Rysz, J., Hernandez, A. V., Bajraktari, G., Mikhalidis, D. P., & Banach, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1135-z · Cited by 57
“…73.1 ± 10.6* 26.5* 35.3* 47.1* 80.3* NR NR NR NR NR NR Nochioka et al. 2015 S C 1163 1961 ≥50% ≥50% 69.0 ± 11.0 69.7 ± 12.9 67.5 64 45 40.8 33.8 20.9 85 76.7 45 40.8 NR NR 1.51 ± 0.82 1.4 ± 0.81 Alehagen U et al. 2015 S C 3427 5713 ≥50% ≥50% 78 ± 12 75 ± 9 29 ± 6 27 ± 6 54 42 31 28 62 64 NR NR NR…”
Influential
Metadata
- Authors
- Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H.
- Venue
- Circulation: Heart Failure
- Published
- 2015-03
- Volume
- 8
- Issue
- 2
- Pages
- 252-260
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2171461709
- Cited by
- 49
- References
- 7
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry. https://app.cochat.ai/papers/10.1161/circheartfailure.114.001730
- The paper
- Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015). Association Between Use of Statins and Outcomes in Heart Failure With Reduced Ejection Fraction: Prospective Propensity Score Matched Cohort Study of 21 864 Patients in the Swedish Heart Failure Registry. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.114.001730
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.